Patient Guide: A Study to Evaluate Safety and Tolerability of CVL-231 (Emraclidine) in Adult Participants With Schizophrenia

Why Use Quri.ai for This Trial?

  • ✓ Simplified eligibility checker - know if you qualify in minutes
  • ✓ Direct contact with study coordinators at 85 locations
  • ✓ Plain language explanations of medical terms and procedures
  • ✓ Personalized enrollment support throughout your journey
  • ✓ Free service - no hidden fees or obligations
Trial ID: NCTNCT05443724
Status: ACTIVE_NOT_RECRUITING
Condition: Schizophrenia
Phase: PHASE2

Where You Can Participate

This study is available at 85 locations across the country.

Top locations include:
  • • Phoenix, Arizona
  • • Bryant, Arkansas
  • • Little Rock, Arkansas
  • • And 82 more locations

Loading interactive enrollment tools...

The full interactive experience will load momentarily

A Study to Evaluate Safety and Tolerability of CVL-231 (Emraclidine) in Adult Participants With Schizophrenia - Join Clinical Trial NCTNCT05443724

How to Join This Clinical Trial - NCTNCT05443724

Learn how to participate in this PHASE2 trial studying an investigational therapy for Schizophrenia. Current status: ACTIVE_NOT_RECRUITING.

Am I Eligible for This Clinical Trial?

This clinical research study is looking for participants with Schizophrenia. Eligibility requirements include specific age ranges, health status, and medical history. Contact the study team to learn if you qualify.

Condition Being Studied
Schizophrenia
Treatment Being Tested
Investigational treatment
Study Phase
PHASE2 - Safety and effectiveness study
Enrollment Status
ACTIVE_NOT_RECRUITING
Study Identifier
NCTNCT05443724 - ClinicalTrials.gov Identifier
Sponsored By
Study sponsor

What to Expect as a Participant

Participating in this clinical trial involves:

  • Initial screening to determine eligibility
  • Regular study visits and health assessments
  • Receiving the study treatment or placebo
  • Medical monitoring and follow-up care
  • Contributing to medical research that may help others
  • Potential access to new treatments before they're widely available

Clinical Trial Benefits and Compensation

Participants in this clinical research study may receive:

  • Close medical monitoring by healthcare professionals
  • Access to potential new treatments
  • Compensation for time and travel (varies by study)
  • No-cost study-related medical care
  • The opportunity to help advance medical knowledge

Where Is This Clinical Trial Located?

This study is enrolling participants at 85 locations. Find a study site near you:

Clinical Research Site

Phoenix, Arizona 85012-2707 - United States

Status: Contact for availability

Clinical Research Site

Bryant, Arkansas 72022-9252 - United States

Status: Contact for availability

Clinical Research Site

Little Rock, Arkansas 72211-3702 - United States

Status: Contact for availability

Clinical Research Site

Anaheim, California 92805-5854 - United States

Status: Contact for availability

Clinical Research Site

Bellflower, California 90706-7079 - United States

Status: Contact for availability

Clinical Research Site

Culver City, California 90230-6632 - United States

Status: Contact for availability

Clinical Research Site

Garden Grove, California 92845-2506 - United States

Status: Contact for availability

Clinical Research Site

La Habra, California 90631-3842 - United States

Status: Contact for availability

Clinical Research Site

Lemon Grove, California 91945-2956 - United States

Status: Contact for availability

Clinical Research Site

Montclair, California 91763-2231 - United States

Status: Contact for availability

And 75 more locations available. Contact us to find the nearest participating site.

How to Enroll in This Study

To learn more about participating in this PHASE2 clinical trial for Schizophrenia:

  1. Review the eligibility criteria with your healthcare provider
  2. Contact the study team for a pre-screening interview
  3. Schedule an in-person screening visit if eligible
  4. Review and sign the informed consent form
  5. Begin participation in the clinical trial

Why Choose Quri.ai Study Finder

Quri.ai's Study Finder is the leading clinical trial business intelligence platform, helping BD professionals:

  • Discover clinical trials before competitors
  • Access exclusive contact information
  • Track sponsor pipelines and opportunities
  • Connect with decision makers directly
  • Win more business partnerships